Stock listing
BE50 Stock Price, News, Filings & Events — Cns Pharmaceuticals, Inc.
Selected listing: BE50 · FWB · EUR · DE
This page tracks Cns Pharmaceuticals, Inc.'s BE50:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BE50:FWB. BE50:FWB is the stock-level entry point for investors researching Cns Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- BE50:FWB
- Asset type
- Stock
- Market cap
- $8.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- FWB
- Currency
- EUR
Cns Pharmaceuticals, Inc. BE50:FWB stock context
This page tracks Cns Pharmaceuticals, Inc.'s BE50:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BE50:FWB. BE50:FWB is the stock-level entry point for investors researching Cns Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Cns Pharmaceuticals, Inc.
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 1, 2026
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
August 27, 2026
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic T...
August 12, 2026
CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Oversubscribed $22.5M Financing, Growth Strategy in Investor Presentation
June 9, 2026
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
June 8, 2026
Research Cns Pharmaceuticals, Inc.
Cns Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for BE50:FWB.
Cns Pharmaceuticals, Inc. company profile
View the public company page for Cns Pharmaceuticals, Inc. on 6ix.
Cns Pharmaceuticals, Inc. news
Read company news and market updates connected to Cns Pharmaceuticals, Inc..
Cns Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Cns Pharmaceuticals, Inc..